Zenta Walther

3.0k total citations
40 papers, 2.1k citations indexed

About

Zenta Walther is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zenta Walther has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Zenta Walther's work include Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (9 papers) and Microtubule and mitosis dynamics (4 papers). Zenta Walther is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (9 papers) and Microtubule and mitosis dynamics (4 papers). Zenta Walther collaborates with scholars based in United States, Italy and South Korea. Zenta Walther's co-authors include James M. Anderson, Pravinkumar B. Sehgal, Malini Vashishtha, Athar H. Chishti, J. L. Hall, Spyros Artavanis‐Tsakonas, David A. Hartley, Jonathan M. Rothberg, L T May and Alexandra R. Cohen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Zenta Walther

38 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zenta Walther United States 19 1.2k 611 356 319 310 40 2.1k
Tien Hsu United States 31 2.0k 1.6× 361 0.6× 284 0.8× 420 1.3× 219 0.7× 72 2.7k
Klaudia Giehl Germany 30 2.1k 1.7× 951 1.6× 749 2.1× 169 0.5× 186 0.6× 52 3.3k
Jaime Millán Spain 29 1.6k 1.3× 858 1.4× 286 0.8× 137 0.4× 159 0.5× 50 2.8k
Gregory E. Hannigan Canada 27 1.9k 1.6× 1.0k 1.7× 477 1.3× 210 0.7× 226 0.7× 41 3.7k
Miguel R. Campanero Spain 29 1.3k 1.0× 353 0.6× 496 1.4× 241 0.8× 232 0.7× 62 3.1k
Jingsong Xu United States 18 1.1k 0.9× 620 1.0× 331 0.9× 109 0.3× 153 0.5× 22 2.3k
Carlo Cenciarelli Italy 28 1.6k 1.3× 195 0.3× 736 2.1× 162 0.5× 144 0.5× 67 2.7k
Ronald van der Neut Netherlands 24 1.2k 1.0× 632 1.0× 418 1.2× 136 0.4× 142 0.5× 32 2.3k
Abdelali Jalil France 26 1.1k 0.9× 520 0.9× 602 1.7× 145 0.5× 142 0.5× 48 3.1k
Clark D. Wells United States 25 1.7k 1.4× 910 1.5× 244 0.7× 214 0.7× 107 0.3× 33 2.4k

Countries citing papers authored by Zenta Walther

Since Specialization
Citations

This map shows the geographic impact of Zenta Walther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zenta Walther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zenta Walther more than expected).

Fields of papers citing papers by Zenta Walther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zenta Walther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zenta Walther. The network helps show where Zenta Walther may publish in the future.

Co-authorship network of co-authors of Zenta Walther

This figure shows the co-authorship network connecting the top 25 collaborators of Zenta Walther. A scholar is included among the top collaborators of Zenta Walther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zenta Walther. Zenta Walther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrova, Zaritza O., et al.. (2024). A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition. npj Precision Oncology. 8(1). 3–3. 3 indexed citations
2.
Cecchini, Michael, Zenta Walther, Wei Wei, et al.. (2023). NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors. Cancer Research Communications. 3(6). 1113–1117. 2 indexed citations
3.
Stockhammer, Paul, Michael J. Grant, Anna Wurtz, et al.. (2023). Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer. Journal of Thoracic Oncology. 19(2). 240–251. 30 indexed citations
4.
Mack, Philip C., Jieling Miao, Mary W. Redman, et al.. (2022). Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI–Treated Patients with EGFR -Mutant NSCLC (SWOG S1403). Clinical Cancer Research. 28(17). 3752–3760. 31 indexed citations
5.
Truini, Anna, Jacqueline H. Starrett, Tyler F. Stewart, et al.. (2019). The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma. Clinical Cancer Research. 25(21). 6382–6391. 38 indexed citations
6.
Cecchini, Michael, Zenta Walther, Jeffrey Sklar, et al.. (2017). Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes. The Lancet Oncology. 19(1). 23–24. 4 indexed citations
7.
Stahl, John M., Zenta Walther, Bryan Chang, Howard S. Höchster, & Kimberly L. Johung. (2017). A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease. Cureus. 9(2). e1007–e1007. 3 indexed citations
8.
Cecchini, Michael, Zenta Walther, Jeffrey Sklar, et al.. (2017). Introduction to the Yale Precision Medicine Tumor Board. The Lancet Oncology. 19(1). 19–20. 2 indexed citations
9.
Bruin, Elza C. de, Catherine Cowell, Patricia H. Warne, et al.. (2014). Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer. Cancer Discovery. 4(5). 606–619. 154 indexed citations
10.
Pirazzoli, Valentina, Caroline A. Nebhan, Xiaoling Song, et al.. (2014). Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1. Cell Reports. 7(4). 999–1008. 56 indexed citations
11.
Hoshi, Namiko, Dominik Schenten, Simone A. Nish, et al.. (2012). MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nature Communications. 3(1). 1120–1120. 108 indexed citations
12.
Walther, Zenta & Dhanpat Jain. (2011). Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International. 2011. 1–15. 44 indexed citations
13.
Walther, Zenta & Jeffrey Sklar. (2011). Molecular Tumor Profiling for Prediction of Response to Anticancer Therapies. The Cancer Journal. 17(2). 71–79. 18 indexed citations
14.
Walther, Zenta & Mark Topazian. (2009). Isospora cholangiopathy: case study with histologic characterization and molecular confirmation. Human Pathology. 40(9). 1342–1346. 24 indexed citations
15.
Abayasekara, Nirmalee, et al.. (2009). CASK Deletion in Intestinal Epithelia Causes Mislocalization of LIN7C and the DLG1/Scrib Polarity Complex without Affecting Cell Polarity. Molecular Biology of the Cell. 20(21). 4489–4499. 17 indexed citations
16.
Maday, Sandra, Eric Anderson, Henry C. Chang, et al.. (2008). A PDZ‐Binding Motif Controls Basolateral Targeting of Syndecan‐1 Along the Biosynthetic Pathway in Polarized Epithelial Cells. Traffic. 9(11). 1915–1924. 34 indexed citations
17.
Achneck, Hardean E., et al.. (2005). Ileostomy Adenocarcinomas in the Setting of Ulcerative Colitis. Journal of Clinical Gastroenterology. 39(5). 396–400. 6 indexed citations
18.
Walther, Zenta & John L. Hall. (1995). The uni chromosome ofChlamydomonas: histone genes and nucleosome structure. Nucleic Acids Research. 23(18). 3756–3763. 10 indexed citations
19.
Walther, Zenta, L T May, & Pravinkumar B. Sehgal. (1988). Transcriptional regulation of the interferon- beta  2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.. The Journal of Immunology. 140(3). 974–977. 163 indexed citations
20.
Rothberg, Jonathan M., David A. Hartley, Zenta Walther, & Spyros Artavanis‐Tsakonas. (1988). slit: An EGF-homologous locus of D. melanogaster involved in the development of the embryonic central nervous system. Cell. 55(6). 1047–1059. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tien Hsu Breakdown of academic impact, for papers by Klaudia Giehl Breakdown of academic impact, for papers by Jaime Millán Breakdown of academic impact, for papers by Gregory E. Hannigan Breakdown of academic impact, for papers by Miguel R. Campanero Breakdown of academic impact, for papers by Jingsong Xu Breakdown of academic impact, for papers by Carlo Cenciarelli Breakdown of academic impact, for papers by Ronald van der Neut Breakdown of academic impact, for papers by Abdelali Jalil Breakdown of academic impact, for papers by Clark D. Wells
Rankless by CCL
2026